Wang Xiaoying, M.S. Med

Department:Gastroenterology

Medical School:Zhejiang University School of Medicine, China

Academic Rank:Associate Chief Physician


Appointment

Clinical / Research Interests

Mucosal disorders of the stomach, small intestine and colon, especially inflammatory bowel disease (ulcerative colitis and Crohn's disease) diagnosis and therapy

Research Summary

Linc-CAD/ANKRD22 promotes by regulating mitochondrial Ca2+ load on the molecular mechanism of macrophage activation

NKRD22/PHLPP promotes ROS production, causing intestinal mucosal barrier damage in inflammatory bowel disease on the molecular mechanism


Publications

Dingting Xu#, Hanyun Zhang#, Xiaoying Wang*. Effects of tin caulis dendrobium polysaccharide on the prevention of non-alcoholic fatty liver disease in rats, Revista Brasileira De Zootecnia-Brazilian Journal of Animal Science. 2017; 46(8): 652-656.

Wang XY#, Chen Y, Du Q. Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia. EUR Rev Med Pharmacol Sci 2013;17:1114-1116.

Wang XY#, Chen ZH, Zhang RY, et al. Construction of a eukaryotic expression vector Pegfp-c1-bmp-2 and its effect on cell migration. 2012;13(5):356-363.


Current Program

ANKRD22/PHLPP promotes Akt mitochondrial translocation and ROS production, causing intestinal mucosal barrier damage in inflammatory bowel disease study on the molecular mechanism of injury. Funding Source: National Natural Science Foundation of China.

Find People

Search by Family Name

Find A Department

Search by Departments